Articles with "comorbidities selection" as a keyword



Photo by nci from unsplash

Influence of cardiovascular (CV) comorbidities on the selection of hormone deprivation therapy (HDT) in the treatment of metastatic prostate cancer (mPCa).

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2018.36.6_suppl.tps392

Abstract: TPS392Background: HDT with LHRH agonists (LHRH) or LHRH-antagonists (degarelix, D) is the standard of care in advanced mPCa. A correlation between leuprolide/goserelin and an increased risk of CV events as compared to D has been… read more here.

Keywords: comorbidities selection; cardiovascular comorbidities; treatment; influence cardiovascular ... See more keywords